IRCT20200105046010N12尚未招募未知
In- Vivo Bioequivalence study of Sitagliptine/ Metformin tablet with brand drugs (JANUMET 50/500mg (Merck Sharp & Dohme, Gremany) in Iranian healthy volunteers.
Razak Pharma0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health (liver, heart, kidney)
- •Body Mass Index (BMI) between 18-28
- •Informed consent
- •Age between 18-60
- •Both male and female
排除标准
- •Hypersensitivity to the drug
- •Alcohol & Drug addiction
研究者
相似试验
尚未招募
不适用
inagliptin / Metformin tablet 2.5/1000mg ABIDI (Liroprim 2.5/1000mg) , In- Vivo Bioequivalence in Iranian healthy volunteers.In this study the bioquivalence of test and brand of LIROPRIM will evaluated..IRCT20200105046010N5Tabriz University of Medical Sciences24
招募中
不适用
Study of Sitagliptine/ Metformin table In-Vivo Bioequivalence in healthy volunteersIRCT20200105046010N20Koushan Pharmed Pharmaceutical Company24
已完成
3 期
The effect of sitagliptin and metformin on the quality of oocyte and embryos, the number of retrieved oocytePolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20220803055607N1Babol University of Medical Sciences76
已完成
不适用
Efficacy and Safety comparison of Sitagliptin and Glimepiride in elderly Japanese patients with type 2 diabetestype 2 diabetesJPRN-UMIN000004047Japan Association for Diabetes Education and Care900
尚未招募
不适用
Comparative in vivo evaluation of 2 Sitagliptin 100 mg Tablet formulationsIRCT20180620040164N27Actover Pharmaceutical Co.24